Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare
Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare
PR75300
AMSTERDAM, Sept. 20, 2018 /PRNewswire=KYODO JBN/ --
Royal Philips [http://www.philips.com/] (NYSE: PHG) (AEX: PHIA), a global
leader in health technology, today released a new Future Health Index (FHI)
report "Moving data to the heart of health systems: Increasing vital technology
adoption to make value-based healthcare a reality"
[https://www.futurehealthindex.com/report/2018/part/2/]. The research focused
on two technology enablers that have the potential to advance integration, and
enable data to be used more effectively. Digital identity tools, such as
Electronic Health Records (EHRs), based on standardized data and protocols that
can be accessed, used and updated by care providers across the health
continuum, can make the collection and exchange of healthcare data much easier.
Data analytics and AI can mine that data for connections and insights that will
benefit both healthcare professionals and patients. This ranges from the
identification of health trends at the level of an entire population, to more
precise diagnosis, treatment and after care for individual patients.
The latest FHI report identifies the following key recommendations for the way
in which health data is collected, shared and used, in order for countries to
meet their goals of driving better value in healthcare:
- Strike the right balance in data protection and (de)regulation
- Foster adoption through education - only 47% of healthcare professionals
surveyed and 24% of the general population felt knowledgeable about connected
care technologies
- Secure buy-in through co-creation of solutions together with healthcare
professionals and the general population
- Harmonize data collection and use practices - countries with universal EHRs
have a higher Value Measure [
] than countries without universal EHRs (47.29 on average vs 39.67), as well as
higher average levels of trust (67.79 vs. 62.99)
"The Future Health Index's latest report
[https://www.futurehealthindex.com/value-measure/] shows that the smooth
exchange of health information is central to delivering better value in
healthcare," said Jan Kimpen, Chief Medical Officer for Philips. "By connecting
people, data and systems we can create a network that allows information to
flow seamlessly across care providers, locations and systems. It is through
data that the outcomes that define value are tracked, measured and improved.
Yet, health systems around the world are still struggling to collect, organize,
analyze and use health data in a meaningful way. The recommendations made in
the FHI are designed to address these very challenges and provide actionable
next steps that healthcare leaders can take to optimize the value provided by
the digital tools they are investing in."
FHI is a research-based platform designed to help determine the readiness of
countries to address global health challenges and build sustainable,
fit-for-purpose national health systems. Using the real-life learning of
experts in the field, and insights uncovered in research, the FHI provides
actionable recommendations for the healthcare industry; particularly around the
adoption and implementation of crucial digital tools that can deliver more
affordable, integrated and sustainable care. A key finding of the FHI is that
integrating connected care technology into health systems can accelerate
countries along the path to value-based healthcare.
To download the Future Health Index 2018 report in its entirety, please visit:
https://www.futurehealthindex.com/report/2018/part-2-moving-data-to-the-heart-of-health-systems.
For additional Future Health Index related content, please visit
https://www.futurehealthindex.com/.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis, treatment
and home care. Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging, image-guided
therapy, patient monitoring and health informatics, as well as in consumer
health and home care. Philips generated 2017 sales of EUR 17.8 billion and
employs approximately 75,000 employees with sales and services in more than 100
countries. News about Philips can be found at http://www.philips.com/newscenter.
For further information, please contact:
Elena Calamo Specchia
Philips Group Press Office
Tel.: +31-6-25004735
E-mail: Elena.Calamo.Specchia@philips.com
SOURCE: Royal Philips
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。